2010Hebei Journal of Traditional Chinese MedicineRequires access

Observation of therapeutic effect of diarrhea-predominant irritable bowel syndrome treated by combination of Berberine and lived combined B. Subtilis and E. Faecium enteric-coated capsules

Yajun Li

Open publisher page 0 citations

Abstract

Objective To observe the therapeutic effect of diarrhea-predominant irritable bowel syndrome treated by combination of Berberine and lived combined B.Subtilis and E.Faecium enteric-coated capsules(Medilac-s).Methods 80 cases of diarrhea-predominant irritable bowel syndrome were randomly divided into two groups.40 patients were in each group.Patients in treatment group were treated by combination of Berberine(300 mg,thrice a day) and Medilac-s(2 pills,thrice a day).40 cases in control group were treated by Berberine(300 mg,thrice a day).The course was three weeks in two groups.Results The total effective rate in treatment group(90%) was higher than that in control group(72.5%,P0.05).Conclusion Combination of Berberine and Medilac-s is safe,effective and inexpensive on the treatment of diarrhea-predominant irritable bowel syndrome.

About this research paper

What this paper is about

Objective To observe the therapeutic effect of diarrhea-predominant irritable bowel syndrome treated by combination of Berberine and lived combined B.Subtilis and E.Faecium enteric-coated capsules(Medilac-s).Methods 80 cases of diarrhea-predominant irritable bowel syndrome were randomly divided into two groups.40 patients were in each group.Patients in treatment group were treated by combination of Berberine(300 mg,thrice a day) and Medilac-s(2 pills,thrice a day).40 cases in control group were treated by Berberine(300 mg,thrice a day).The course was three weeks in two groups.Results The total effective rate in treatment group(90%) was higher than that in control group(72.5%,P0.05).Conclusion Combination of Berberine and Medilac-s is safe,effective and inexpensive on the treatment of diarrhea-predominant irritable bowel syndrome.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the therapeutic effect of diarrhea-predominant irritable bowel syndrome treated by combination of Berberine and lived combined B.Subtilis and E.Faecium enteric-coated capsules(Medilac-s).Methods 80 cases of diarrhea-predominant irritable bowel syndrome were randomly divided into two groups.40 patients were in each group.Patients in treatment group were treated by combination of Berberine(300 mg,thrice a day) and Medilac-s(2 pills,thrice a day).40 cases in control group were treated by Berberine(300 mg,thrice a day).The course was three weeks in two groups.Results The total effective rate in treatment group(90%) was higher than that in control group(72.5%,P0.05).Conclusion Combination of Berberine and Medilac-s is safe,effective and inexpensive on the treatment of diarrhea-predominant irritable bowel syndrome.

Key concepts: Irritable bowel syndrome, Medicine, Diarrhea, Berberine, Gastroenterology, Internal medicine, Therapeutic effect, Defecation

Related papers

Back to paper searchBrowse research topicsOriginal source
Observation of therapeutic effect of diarrhea-predominant irritable bowel syndrome treated by combination of Berberine and lived combined B. Subtilis and E. Faecium enteric-coated capsules — Research Paper | ScholarLens